Cargando…
Combination of mometasone furoate and oxymetazoline for the treatment of adenoid hypertrophy concomitant with allergic rhinitis: A randomized controlled trial
In the clinic, approximately 30% of children with adenoid hypertrophy (AH) concomitant with allergic rhinitis (AR) report poor responses to intranasal steroids. To determine whether the combination of mometasone furoate (MF) and oxymetazoline (OXY) is more effective than either agent alone, we perfo...
Autores principales: | Liu, Wenlong, Zhou, Lifeng, Zeng, Qingxiang, Luo, Renzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241667/ https://www.ncbi.nlm.nih.gov/pubmed/28098165 http://dx.doi.org/10.1038/srep40425 |
Ejemplares similares
-
Effects of intranasal mometasone furoate on blood pressure in patients with allergic rhinitis
por: Kartal, O., et al.
Publicado: (2018) -
A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016) -
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021) -
Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
por: Rizzi, Angela, et al.
Publicado: (2022) -
Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)